CRX and Leber congenital amaurosis: To model genetic heterogeneity of LCA, elucidate disease mechanisms, and evaluate possible treatment paradigms, we recently established retinal organoid culture systems from iPSCs of patients with LCA with mutations in CEP290 and CRX (Kruczek et al., 2021; Shimada et al., 2017).